Search icon

CODAGENIX INC.

Company Details

Name: CODAGENIX INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 01 Apr 2009 (16 years ago)
Entity Number: 3793440
ZIP code: 11735
County: Nassau
Place of Formation: Delaware
Address: 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, United States, 11735

Commercial and government entity program

CAGE number Status Type Established CAGE Update Date CAGE Expiration SAM Expiration
5D8K5 Active Non-Manufacturer 2009-03-26 2024-09-16 2029-09-16 2025-09-12

Contact Information

POC JEFFREY FU
Phone +1 484-358-6843
Address 3 BIOSCIENCE PARK DR BLDG II STE 501, FARMINGDALE, NASSAU, NY, 11735, UNITED STATES

Ownership of Offeror Information

Highest Level Owner Information not Available
Immediate Level Owner Information not Available
List of Offerors (0) Information not Available

DOS Process Agent

Name Role Address
CODAGENIX INC. DOS Process Agent 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, United States, 11735

Chief Executive Officer

Name Role Address
JOHN ROBERT COLEMAN Chief Executive Officer 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, United States, 11735

History

Start date End date Type Value
2023-04-06 2023-04-06 Address 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, 11735, USA (Type of address: Chief Executive Officer)
2021-04-27 2023-04-06 Address 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, 11735, USA (Type of address: Service of Process)
2020-11-16 2023-04-06 Address 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, 11735, USA (Type of address: Chief Executive Officer)
2020-01-07 2020-11-16 Address 3 BIOSCIENCE PARK DRIVE, FARMINGDALE, NY, 11735, USA (Type of address: Principal Executive Office)
2011-05-09 2020-01-07 Address 7 GAY DRIVE, GREAT NECK, NY, 11024, USA (Type of address: Principal Executive Office)
2011-05-09 2020-11-16 Address 7 GAY DRIVE, GREAT NECK, NY, 11024, USA (Type of address: Chief Executive Officer)
2009-04-01 2021-04-27 Address 5211 15TH AVE., BROOKLYN, NY, 11219, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
230406000507 2023-04-06 BIENNIAL STATEMENT 2023-04-01
211220000851 2021-12-20 BIENNIAL STATEMENT 2021-12-20
210427000210 2021-04-27 CERTIFICATE OF CHANGE 2021-04-27
201116002020 2020-11-16 AMENDMENT TO BIENNIAL STATEMENT 2019-04-01
200107061151 2020-01-07 BIENNIAL STATEMENT 2019-04-01
130422002114 2013-04-22 BIENNIAL STATEMENT 2013-04-01
110509002356 2011-05-09 BIENNIAL STATEMENT 2011-04-01
090401000332 2009-04-01 APPLICATION OF AUTHORITY 2009-04-01

Awards

Contract Type Award or IDV Flag PIID Start Date Current End Date Potential End Date
DEFINITIVE CONTRACT AWARD 75A50123C00048 2023-09-30 2024-12-31 2026-07-31
Unique Award Key CONT_AWD_75A50123C00048_7505_-NONE-_-NONE-
Awarding Agency Department of Health and Human Services
Link View Page

Award Amounts

Obligated Amount 10000000.00
Current Award Amount 57630647.00
Potential Award Amount 389449173.00

Description

Title CONDUCT A PHASE 2B EFFICACY STUDY AS PRESCRIBED IN AOI15 WITH COVILIV A PROPRIETARY LIVE ATTENUATED VIRUS COVID-19 VACCINE.
NAICS Code 541714: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Product and Service Codes AN42: HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH

Recipient Details

Recipient CODAGENIX INC.
UEI TEMNL437K2F1
Recipient Address UNITED STATES, 3 BIOSCIENCE PARK DR, FARMINGDALE, SUFFOLK, NEW YORK, 117351019

Date of last update: 17 Jan 2025

Sources: New York Secretary of State